Role of teprotumumab in the treatment of active moderate-to-severe Graves' orbitopathy.
Sign Up to like & getrecommendations! Published in 2022 at "European thyroid journal"
DOI: 10.1530/etj-22-0185
Abstract: Graves' orbitopathy (GO), also named thyroid-associated orbitopathy (TAO) or thyroid-eye disease (TED), is an autoimmune inflammatory disease of the orbit and the most important extrathyroidal manifestation of Graves' disease. After an initial inflammatory ("active") phase… read more here.
Keywords: role teprotumumab; graves orbitopathy; treatment active; active moderate ... See more keywords